Eris Lifesciences Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported revenue was INR 3,666.57 million compared to INR 3,320.76 million a year ago. Net income was INR 1,183.93 million compared to INR 1,077.2 million a year ago. Basic earnings per share from continuing operations was INR 8.71 compared to INR 7.93 a year ago. Diluted earnings per share from continuing operations was INR 8.71 compared to INR 7.93 a year ago. For the six months, revenue was INR 7,217.92 million compared to INR 626,637 million a year ago. Net income was INR 2,250.52 million compared to INR 1,967.38 million a year ago. Basic earnings per share from continuing operations was INR 16.57 compared to INR 14.49 a year ago. Diluted earnings per share from continuing operations was INR 16.56 compared to INR 14.48 a year ago.